価格表

在庫・価格 : 2024年04月28日 15時31分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Neuropilin-1, Human, Recombinant, Carrier-free
データシート
3870-N1-025 RSDアールアンドディー システムス
R&D Systems, Inc.
25 μg ¥93,000
(未発注)
追加

在庫・価格 : 2024年04月28日 15時31分 現在

Neuropilin-1, Human, Recombinant, Carrier-free

  • 商品コード:3870-N1-025
  • メーカー:RSD
  • 包装:25μg
  • 価格: ¥93,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Lepelletier Y et al. Immunosuppressive role of semaphorin-3A on T cell proliferation is mediated by inhibition of actin cytoskeleton reorganization. Eur. J. Immunol. 2006 Jul;36(7):1782-93
Lepelletier Y et al
2006/01/01
Species: Human, Application: Bioassay, Sample type: Whole Cells PubMed
2 Jaalouk DE et al. The original Pathologische Anatomie Leiden-Endothelium monoclonal antibody recognizes a vascular endothelial growth factor binding site within neuropilin-1. Cancer Res. 2007 Oct;67(20):9623-9
Jaalouk DE et al
2007/01/01
Species: Mouse, Application: Bioassay, Sample type: NRP-1 Protein, PAL-E Protein PubMed
3 Sulpice E et al. Neuropilin-1 and neuropilin-2 act as coreceptors, potentiating proangiogenic activity. Blood 2008 Feb;111(4):2036-45
Sulpice E et al
2008/01/01
Species: Human, Application: Binding Assay, recombinant HGF, recombinant VEGF PubMed
4 Conrad AH et al. Proteomic analysis of potential keratan sulfate, chondroitin sulfate A, and hyaluronic acid molecular interactions. Invest. Ophthalmol. Vis. Sci. 2010 Sep;51(9):4500-15
Conrad AH et al
2010/01/01
Application: Other: See notes, Sample Type: Other: Corneal Stromal GAGs PubMed
5 Narazaki M et al. Oligo-guanosine nucleotide induces neuropilin-1 internalization in endothelial cells and inhibits angiogenesis. Blood 2010 Oct;116(16):3099-107
Narazaki M et al
2010/01/01
Application: Biacore binding study,Binding Assay, Sample Type: biotin-deoxyadenosine,biotin-deoxycytidine,biotin-deoxyguanine 18,biotin-deoxythymidine PubMed
6 Uniewicz KA et al. Exogenous recombinant dimeric neuropilin-1 is sufficient to drive angiogenesis. J. Biol. Chem. 2011 Jan;286(1):12-23
Uniewicz KA et al
2011/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
7 Wilson TR et al. Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors. Nature 2012 Jul;487(7408):505-9
Wilson TR et al
2012/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
8 Harris NC et al. The propeptides of VEGF-D determine heparin binding, receptor heterodimerization, and effects on tumor biology. J. Biol. Chem. 2013 Mar;288(12):8176-86
Harris NC et al
2013/01/01
Application: Precipitation, Sample Type: Media PubMed
9 Teran M et al. Synergistic Binding of Vascular Endothelial Growth Factor-A and Its Receptors to Heparin Selectively Modulates Complex Affinity. J. Biol. Chem. 2015 Jun;290(26):16451-62
Teran M et al
2015/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
  • No.: 1
  • 文献情報:
    Lepelletier Y et al. Immunosuppressive role of semaphorin-3A on T cell proliferation is mediated by inhibition of actin cytoskeleton reorganization. Eur. J. Immunol. 2006 Jul;36(7):1782-93
    Lepelletier Y et al
    2006/01/01
  • 備考:
    Species: Human, Application: Bioassay, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Jaalouk DE et al. The original Pathologische Anatomie Leiden-Endothelium monoclonal antibody recognizes a vascular endothelial growth factor binding site within neuropilin-1. Cancer Res. 2007 Oct;67(20):9623-9
    Jaalouk DE et al
    2007/01/01
  • 備考:
    Species: Mouse, Application: Bioassay, Sample type: NRP-1 Protein, PAL-E Protein
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Sulpice E et al. Neuropilin-1 and neuropilin-2 act as coreceptors, potentiating proangiogenic activity. Blood 2008 Feb;111(4):2036-45
    Sulpice E et al
    2008/01/01
  • 備考:
    Species: Human, Application: Binding Assay, recombinant HGF, recombinant VEGF
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Conrad AH et al. Proteomic analysis of potential keratan sulfate, chondroitin sulfate A, and hyaluronic acid molecular interactions. Invest. Ophthalmol. Vis. Sci. 2010 Sep;51(9):4500-15
    Conrad AH et al
    2010/01/01
  • 備考:
    Application: Other: See notes, Sample Type: Other: Corneal Stromal GAGs
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Narazaki M et al. Oligo-guanosine nucleotide induces neuropilin-1 internalization in endothelial cells and inhibits angiogenesis. Blood 2010 Oct;116(16):3099-107
    Narazaki M et al
    2010/01/01
  • 備考:
    Application: Biacore binding study,Binding Assay, Sample Type: biotin-deoxyadenosine,biotin-deoxycytidine,biotin-deoxyguanine 18,biotin-deoxythymidine
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Uniewicz KA et al. Exogenous recombinant dimeric neuropilin-1 is sufficient to drive angiogenesis. J. Biol. Chem. 2011 Jan;286(1):12-23
    Uniewicz KA et al
    2011/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Wilson TR et al. Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors. Nature 2012 Jul;487(7408):505-9
    Wilson TR et al
    2012/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Harris NC et al. The propeptides of VEGF-D determine heparin binding, receptor heterodimerization, and effects on tumor biology. J. Biol. Chem. 2013 Mar;288(12):8176-86
    Harris NC et al
    2013/01/01
  • 備考:
    Application: Precipitation, Sample Type: Media
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Teran M et al. Synergistic Binding of Vascular Endothelial Growth Factor-A and Its Receptors to Heparin Selectively Modulates Complex Affinity. J. Biol. Chem. 2015 Jun;290(26):16451-62
    Teran M et al
    2015/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed